Abstract
Ginsenoside Rh2, a plant glycoside with a dammarane skeleton resembling a steroid skeleton as an aglycone, has anticancer potentials in vitro or in vivo. To elucidate the molecular mechanisms of the effects of Rh2, we have examined the Cyclin-dependent kinase-2 (Cdk2) activity in G1 arrested B16 melanoma cells and in S phase-arrested Meth-A sarcoma cells, that have been treated with Rh2. The kinase activity was suppressed in B16 cells but not in Meth-A cells. In addition, Rh2 was found to induce G1 arrest and concomitantly suppress the Cdk2 activity in carcinogen-susceptible BALB/c 3T3 A31-1-1 and A31-1-13 cell lines. Thus, Rh2 has a G1 phase-specific suppressive effect on the Cdk2 activity, supporting further evaluation of Rh2 and its related compounds in cancer chemoprevention studies.
References
Dec 1, 1979·Endocrinologia Japonica·S HiaiS Yano
Sep 18, 1992·Science·A KoffJ M Roberts
Feb 14, 1992·Biochemical and Biophysical Research Communications·F ZindyC Bréchot
Sep 12, 1991·Nature·L H TsaiM Meyerson
Dec 1, 1991·Journal of Pharmaceutical Sciences·T OtaS Odashima
Dec 20, 1991·Cell·F GirardN J Lamb
Aug 23, 1990·Nature·J Pines, T Hunter
May 1, 1987·Cancer·H HanaueJ Shikata
Apr 15, 1985·Cancer·B L Andersen
Oct 1, 1982·Endocrinologia Japonica·P T PearceJ W Funder
Oct 25, 1980·British Medical Journal·R Punnonen, A Lukola
Jul 25, 1980·Science·T Kakunaga, J D Crow
Jan 1, 1995·Life Sciences·S W ChoS Y Choi
Jul 27, 1995·Nature·Y TeradaH Okayama
Mar 9, 1995·Nature·D O Morgan
Nov 18, 1994·Cell·C J Sherr
Nov 18, 1994·Cell·T Hunter, J Pines
Jun 30, 1986·Physical Review Letters·P HaasR Kowalewski
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Citations
Mar 2, 2005·Cancer Chemotherapy and Pharmacology·Chi-Chih ChengShih-Lan Hsu
Aug 6, 2000·Biochemical Pharmacology·S J LeeB H Lee
Feb 12, 1998·Cancer Letters·J A ParkS K Lee
Jan 25, 2005·Acta Pharmacologica Sinica·Yong ChengJun-Tian Zhang
Jul 26, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Xiao-Jia ChenJian-Li Gao
Jun 25, 2019·Seminars in Cancer Biology·Fabrizio FontanaPatrizia Limonta